Does RIVAROXABAN Cause Cholangiocarcinoma? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Cholangiocarcinoma have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.0% of all adverse event reports for RIVAROXABAN.
9
Reports of Cholangiocarcinoma with RIVAROXABAN
0.0%
of all RIVAROXABAN reports
7
Deaths
9
Hospitalizations
How Dangerous Is Cholangiocarcinoma From RIVAROXABAN?
Of the 9 reports, 7 (77.8%) resulted in death, 9 (100.0%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Cholangiocarcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Cholangiocarcinoma?
RANITIDINE (100)
ADALIMUMAB (62)
TACROLIMUS (56)
METHOTREXATE (55)
INFLIXIMAB (54)
LENALIDOMIDE (49)
PREDNISONE (48)
MYCOPHENOLATE MOFETIL (45)
PEMIGATINIB (44)
CYCLOPHOSPHAMIDE (42)
Which RIVAROXABAN Alternatives Have Lower Cholangiocarcinoma Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM